| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Context Therapeutics Inc. | Chief Medical Officer | Stock Option (right to buy) | 174,960 | 13 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CNTX | Context Therapeutics Inc. | 13 Feb 2025 | 1 | $0 | 4 | Chief Medical Officer | 14 Feb 2025, 16:07 |
| CNTX | Context Therapeutics Inc. | 01 Aug 2024 | 1 | $0 | 4 | Chief Medical Officer | 01 Aug 2024, 17:18 |
| CNTX | Context Therapeutics Inc. | 01 Aug 2024 | 0 | $0 | 3 | Chief Medical Officer | 01 Aug 2024, 17:15 |